Publication
ESG and Internal Investigations: New Compliance Challenges
“ESG” refers to a set of criteria used to measure a company’s non-financial ethical and sustainability practices.
Current controversy around the waiver of intellectual property rights for COVID-19 Vaccines and implications for life sciences companies
The Life Sciences Lawyer Magazine
As the COVID pandemic lumbers on to its third year, there continues to be global disparities in access to the tools (i.e., vaccines and therapeutics) necessary to combat the pandemic.
A core reason behind this disparity is the developing world’s lack of access to the intellectual property (and technical know-how) required to manufacture these vital vaccines and therapeutics. In 2021, the United States announced that it would support the temporary waiver of intellectual property protections for COVID-19 vaccines under the Trade Related Aspects of Intellectual Property Rights (“TRIPS”) Agreement.
This article explores the current controversy around the waiver of intellectual property rights for COVID-19 vaccines and therapeutics and their implications for life sciences companies.
Read the full article from The Life Sciences Lawyer Magazine, "Current controversy around the waiver of intellectual property rights for COVID-19 Vaccines and implications for life sciences companies."
Partner-in-Charge, San Francisco
Email
jason.novak@nortonrosefulbright.com
Recent publications
Publication
SFO sets out its new Business Plan: four key takeaways
The SFO’s Business Plan for 2025-2026 signals its intention to take centre stage in global financial crime enforcement, setting out its vision to be a “proactive, authoritative player in the global and domestic justice system”.
Publication
New EU Product Recall Requirements under the General Product Safety Regulation: What do companies need to know?
Managing a product recall is a challenging scenario for any company as product recalls often need to be conducted urgently and can have long-term consequences. Poorly managed recalls can have devastating effects in terms of losing customer loyalty and increased regulatory scrutiny.
Subscribe and stay up to date with the latest legal news, information and events . . .